601 Pennsylvania Avenue, N.W.

Suite 900, South Building

Washington, D.C.  20004-2601

Tel: 202-220-3172

Fax: 202-639-8238

www.NRLN.org

 

 

Board of Directors:

A. J. (Jim) Norby

President

 

Bill Kadereit

Vice President

 

John Leasher

Vice President

Secretary/Treasurer

 

Jane Banfield

Joseph R. (Dick) Ciocca

Robert Foresta

JoAnn Alix-Gagain

Chuck Gilbert

 

-------------------------------

Counsel:

Michael Calabrese

Phyllis Borzi

 

Legislative Counsel:

Marta Bascom

 

Media Relations Director:
Ed Beltram

 

Member Organizations:

Aetna Retirees Association

Ameritech/SBC Retirees

AT&T Retirees (ACE)

Boeing/SPEEA Retirees (Engineering Society)

CWA-CUTW Retirees

Daimler-Chrysler Retirees

Association

Detroit Edison Alliance of  Retirees (DEAR)

GM Retirees-Detroit Diesel

IBM Retirees

Johns Manville Retirees

Lucent Retirees Organization

Monsanto/Solutia Retirees

NAPRI (Prudential)

NWB/US WEST/Qwest

Retiree Association

Portland GE-Enron

Southern New England Tell 

Retirees Association, Inc. (SRA)

TelCo Retirees Association

 

 

The Honorable Byron L. Dorgan

United States Senate

322 Hart Senate Office Building

Washington, DC 20510

 

Dear Senator Dorgan:

 

I was pleased to read this week in news articles and your press release that you are continuing to push for legislation to allow Americans to purchase lower-priced and safe prescription drugs from Canada and other Western industrialized nations.  On behalf of the some 2 million retirees and workers represented by the National Retiree Legislative Network, I want you to know that we endorse the Pharmaceutical Market Access and Drug Safety Act of 2007 (S. 242).

 

We commend you for chairing a hearing before the Senate Commerce Subcommittee on Trade and calling attention to the fact the same drugs, manufactured in the same factory, routinely sell for nearly two times as much in the U.S. as they do in other countries. Americans—especially retirees living on fixed incomes—can no longer afford the high prices on drugs that are maintained through the monopoly power of pharmaceutical companies.

 

We believe that now is the time for Congress to take action on health care issues important to retirees and workers, such as, your bill.  Americans should not have to continue to endure higher drug prices while the drug industry endeavors to water down or side track your bill.

 

Please let me know if the NRLN can assist you in spreading the word about the importance of providing American consumers with competitively priced and safe drugs through legal importation.

 

Sincerely yours,

President, National Retiree Legislative Network

 

return to NRLN HOME PAGE